Safety Evaluation of DREPADOM - Home Care Services and Hospitalizations for Sickle Cell Disease Patients
CompletedOBSERVATIONAL
Enrollment
100
Participants
Timeline
Start Date
February 1, 2021
Primary Completion Date
February 1, 2022
Study Completion Date
June 1, 2022
Conditions
Sickle Cell Disease
Trial Locations (1)
94000
Henri Mondor Hospital, Créteil
All Listed Sponsors
lead
Soutien aux Actions contre les Maladies du Globule Rouge
OTHER
NCT05649280 - Safety Evaluation of DREPADOM - Home Care Services and Hospitalizations for Sickle Cell Disease Patients | Biotech Hunter | Biotech Hunter